Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 17,301–17,320 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass II

Cyanocobalamin Injection, all strengths and all presentations including a) Cyanocobalamin 1000mcg, b) Cyanocobalamin 1000 mcg/mL in 1 mL, 10 mL, and 30 mL and 1 mL Preservative Free, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Vitamin D3 Injection, all strengths and all presentations including a) Cholecalciferol D3 50,000iu 30 mL, b) Calcitriol D3 10,000iu, and c) Calcitriol D3 50,000iu, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Buprenorphine Injection, all strengths and all presentations including Buprenorphine-0.3 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bupivacaine Injection, all strengths and all presentations including a) Bupivacaine Parabens Free 0.5% 50 mL, and b) Bupivacaine PF 0.5% 30 mL SDV, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bupivacaine and Dexamethasone Injection, all strengths and all presentations including Bupiv_Dexameth-0.25-10.5; Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Biotin Injection, all strengths and all presentations including Biotin-15-30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Betamethasone Combination with Lidocaine 1% and Bupivacaine 0.5 % Injection, all strengths and all presentations including a) Betameth combo 6 mg/mL lido 1% bup 0.5% syr; and b) Betameth Combo/Lidocaine 1%/ Bupivacaine 0.5% Syr, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Betamethasone Sodium Phosphate Injection, all strengths and all presentations including 6 mg/2 mL PF and 6 mg/mL; Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

BET-ACE-LIDO-6-2 Injection, all strengths and all presentations including 7 mL syringe and Betameth Combo 6 mg/mL Lidocaine 2% Syringe, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Betamethasone Combination Injection, all strengths and all presentations including a) Beta combo 6 mg/mL, 3 mL, b) Betameth_Combo_PF-6-2 Syr, and c) Betamethasone Combo 6 mg/mL Syr, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

B-Complex Injection, all strengths and all presentations including a) B-Complex Injection 30 mL; b) B-Complex PF 2 mL; c) B-Complex Plus-100; d) B-Complex_B12_30 mL; e) B-Complex-50-Methyl-30-Lido 30 mL; f) B-CompSuper-30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bacteriostatic Water for Injection, all presentations including 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Betamethasone Acetate and Betamethasone Sodium Injection, all strengths and all presentations including 6 mg/mL preservative free, 2 ml; 106 mg/mL 10 mL, and 6 mg/mL 5 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Ascorbic Acid Injection, all strengths and all presentations including a) 500 mg/mL, b) corn source 500 mg/mL, c) tapioca 500 mg/mL, d) cassave 500; Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Amikacin Injection, all strengths and all presentations including 50, 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Alpha Lipoic Acid Injection, all strengths and all presentations including 25 mg/mL, 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Acetylcysteine Injection, all strengths and all presentations including 100 mg/mL in 30 mL vials and 200 mg/mL in 30 mL and 50 mL vials, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

by FVS Holdings, Inc. dba. Green Valley Drugs

Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Recall initiated
April 10, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

CASANOVA Capsules, 450 mg, MALE SEXUAL ENHANCER, supplied i n1 count blister packs, UPC 736211906892; Distributed by: Casanova Distributors, Tucker, GA

by Performance Plus Marketing, Inc.

Reason
Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs
Recall initiated
December 17, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Mojo nights SUPREME Capsules, 1000 mg, Male Sexual Enhancer, supplied in 1 count blister packs, UPC 610585435915; Distributed By: Mojo Health, Pompano Beach, FL

by Performance Plus Marketing, Inc.

Reason
Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs
Recall initiated
December 17, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Mojo nights Capsules, Male Sexual Enhancer, supplied in 1 and 5 count blister packs, Distributed By: Mojo Health, Pompano Beach, FL I count blister UPC - 718122119738; 5 count blister UPC - 705105836430;

by Performance Plus Marketing, Inc.

Reason
Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs
Recall initiated
December 17, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.